(Q74667612)
Statements
VIP (etoposide, ifosfamide and cisplatinum) as a salvage intensification program in relapsed or refractory Hodgkin's disease (English)
Ribrag V
Nasr F
Bouhris JH
Bosq J
Brault P
Girinsky T
Cosset JM
Munck JN
Corti C
Decaudin D
Pico JL
Hayat M